失血性休克与创伤性全肺切除术后的急性右心衰竭——一种管理策略:使用吸入一氧化氮的盲法随机对照动物试验
研究采用失血性休克与全肺切除术羊模型,随机分为吸入一氧化氮20 ppm组(n=9)或氮气安慰剂组(n=9),给予肺保护性通气并连续监测血流动力学、气体交换和血液化学,超声评估心功能。失血至平均动脉压降至基线50%后,经正中胸骨切开行左肺门结扎,同时回输自体血并启动研究气体,监测4小时。所有动物肺血管阻力初始均升高;安慰剂组持续升高,一氧化氮组降至基线。超声显示一氧化氮组右心室功能改善而安慰剂组仍受损;一氧化氮组分流与乳酸先升高、SvO2先降低后均向基线恢复,安慰剂组仍异常。作者认为吸入一氧化氮可能作为临床辅助手段,用于减轻创伤性全肺切除术后的右心衰竭并改善生存。
要点
- 羊失血性休克与全肺切除术模型中,吸入一氧化氮20 ppm组(n=9)肺血管阻力降至基线,氮气安慰剂组(n=9)肺血管阻力持续升高。
- 超声显示吸入一氧化氮组右心室功能改善,安慰剂组右心室功能仍受损。
- 吸入一氧化氮组分流与乳酸初始升高、SvO2初始降低后均向基线恢复,安慰剂组仍异常。
- 作者认为吸入一氧化氮可能通过降低肺血管阻力、减轻右心室后负荷,在需要创伤性全肺切除术时作为临床辅助手段。
适用人群与场景
- 失血性休克与全肺切除术的羊动物模型,接受肺保护性通气。
处置流程与药物剂量
- 失血至平均动脉压降至基线50%后启动复苏:经正中胸骨切开行左肺门结扎,同时回输自体血并启动研究气体。
- 研究气体为吸入一氧化氮20 ppm(n=9)或氮气作为安慰剂(n=9),监测4小时。
研究设计与关键结果
- 盲法随机对照动物试验,羊模型,吸入一氧化氮20 ppm组n=9、氮气安慰剂组n=9。
- 所有动物肺血管阻力初始均升高;安慰剂组肺血管阻力持续升高,吸入一氧化氮组降至基线。
- 超声显示吸入一氧化氮组右心室功能改善,安慰剂组仍受损。
- 吸入一氧化氮组分流与乳酸初始升高、SvO2初始降低后均向基线恢复,安慰剂组仍异常。
证据类型、等级与局限
- 证据类型:盲法随机对照动物试验(羊模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,吸入一氧化氮可能是有用的临床辅助手段,用于减轻创伤性全肺切除术后的右心衰竭并改善生存。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hemorrhagic shock and pneumonectomy causes an acute increase in pulmonary vascular resistance (PVR). The increase in PVR and right ventricular (RV) afterload leads to acute RV failure, thus reducing left ventricular (LV) preload and output. Inhaled nitric oxide (iNO) lowers PVR by relaxing pulmonary arterial smooth muscle without remarkable systemic vascular effects. We hypothesized that with hemorrhagic shock and pneumonectomy, iNO can be used to decrease PVR and mitigate right heart failure.
METHODS: A hemorrhagic shock and pneumonectomy model was developed using sheep. Sheep received lung protective ventilatory support and were instrumented to serially obtain measurements of hemodynamics, gas exchange, and blood chemistry. Heart function was assessed with echocardiography. After randomization to study gas of iNO 20 ppm (n = 9) or nitrogen as placebo (n = 9), baseline measurements were obtained. Hemorrhagic shock was initiated by exsanguination to a target of 50% of the baseline mean arterial pressure. The resuscitation phase was initiated, consisting of simultaneous left pulmonary hilum ligation, via median sternotomy, infusion of autologous blood and initiation of study gas. Animals were monitored for 4 hours.
RESULTS: All animals had an initial increase in PVR. PVR remained elevated with placebo; with iNO, PVR decreased to baseline. Echo showed improved RV function in the iNO group while it remained impaired in the placebo group. After an initial increase in shunt and lactate and decrease in SvO2, all returned toward baseline in the iNO group but remained abnormal in the placebo group.
CONCLUSION: These data indicate that by decreasing PVR, iNO decreased RV afterload, preserved RV and LV function, and tissue oxygenation in this hemorrhagic shock and pneumonectomy model. This suggests that iNO may be a useful clinical adjunct to mitigate right heart failure and improve survival when trauma pneumonectomy is required.
参考来源
- Lubitz AL, Sjoholm LO, Goldberg A, et al. Acute right heart failure after hemorrhagic shock and trauma pneumonectomy-a management approach: A blinded randomized controlled animal trial using inhaled nitric oxide. J Trauma Acute Care Surg. 2017. PMID: 28107308. doi:10.1097/TA.0000000000001325
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。